Camille Verry

1.5k total citations
36 papers, 731 citations indexed

About

Camille Verry is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Camille Verry has authored 36 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 15 papers in Radiation and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Camille Verry's work include Advanced Radiotherapy Techniques (13 papers), Radiation Therapy and Dosimetry (13 papers) and Prostate Cancer Diagnosis and Treatment (9 papers). Camille Verry is often cited by papers focused on Advanced Radiotherapy Techniques (13 papers), Radiation Therapy and Dosimetry (13 papers) and Prostate Cancer Diagnosis and Treatment (9 papers). Camille Verry collaborates with scholars based in France, United States and Switzerland. Camille Verry's co-authors include Olivier Tillement, François Lux, Sandrine Dufort, Jacques Balosso, Yannick Crémillieux, Géraldine Le Duc, Lucie Sancey, Emmanuel Barbier, Guillaume Bort and Sylvie Grand and has published in prestigious journals such as Scientific Reports, Science Advances and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Camille Verry

33 papers receiving 729 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Camille Verry France 12 377 359 240 176 163 36 731
Pierre Mowat France 11 358 0.9× 351 1.0× 252 1.1× 155 0.9× 138 0.8× 12 763
Monique van Prooijen Canada 12 288 0.8× 572 1.6× 176 0.7× 165 0.9× 320 2.0× 23 932
David Kryza France 15 216 0.6× 222 0.6× 177 0.7× 204 1.2× 51 0.3× 55 782
Hovanes Kalaigian United States 9 378 1.0× 251 0.7× 264 1.1× 443 2.5× 129 0.8× 11 1.1k
Nathan A. Koonce United States 13 269 0.7× 151 0.4× 124 0.5× 138 0.8× 86 0.5× 30 766
Ray R. Zhang United States 11 352 0.9× 190 0.5× 46 0.2× 135 0.8× 115 0.7× 17 706
Rasmus I. Jølck Denmark 17 225 0.6× 150 0.4× 220 0.9× 189 1.1× 145 0.9× 31 668
Brian Madajewski United States 15 509 1.4× 299 0.8× 249 1.0× 180 1.0× 23 0.1× 21 990
Andrew N. Fontanella United States 17 363 1.0× 156 0.4× 91 0.4× 190 1.1× 77 0.5× 29 876
Joseph J. Grudzinski United States 14 329 0.9× 256 0.7× 52 0.2× 348 2.0× 89 0.5× 44 924

Countries citing papers authored by Camille Verry

Since Specialization
Citations

This map shows the geographic impact of Camille Verry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camille Verry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camille Verry more than expected).

Fields of papers citing papers by Camille Verry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Camille Verry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camille Verry. The network helps show where Camille Verry may publish in the future.

Co-authorship network of co-authors of Camille Verry

This figure shows the co-authorship network connecting the top 25 collaborators of Camille Verry. A scholar is included among the top collaborators of Camille Verry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Camille Verry. Camille Verry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bellier, Alexandre, et al.. (2024). Outcomes of adjuvant lymph node field radiotherapy and immunotherapy for stage III melanoma. Cancer/Radiothérapie. 28(8). 633–639.
2.
3.
Schick, Ulrike, Vincent Bourbonne, François Lucia, & Camille Verry. (2024). Use of nanoparticles in radiation oncology. Cancer/Radiothérapie. 28(6-7). 618–622. 1 indexed citations
4.
Verry, Camille, et al.. (2024). Treatment planning with high-resolution 3D dose maps in preclinical and translational synchrotron microbeam radiation therapy. Physics and Imaging in Radiation Oncology. 30. 100565–100565. 1 indexed citations
5.
Verry, Camille, Evangelia Kaza, Sandrine Dufort, et al.. (2024). Quantifying gadolinium-based nanoparticle uptake distributions in brain metastases via magnetic resonance imaging. Scientific Reports. 14(1). 11959–11959. 13 indexed citations
6.
Sauerwein, W., Thomas Fischer, Lucie Sancey, et al.. (2023). Principles, Recent Developmentsand Perspectives in Boron NeutronCapture Therapy (BNCT). Bio-Algorithms and Med-Systems. 19(1). 48–53. 3 indexed citations
7.
Gallin-Martel, L., M.-L. Gallin-Martel, J.-F. Muraz, et al.. (2023). Monocrystalline diamond detector for online monitoring during synchrotron microbeam radiotherapy. Journal of Synchrotron Radiation. 30(6). 1076–1085. 7 indexed citations
8.
Loganadane, Gokoulakrichenane, Camille Verry, Allan Thiolat, et al.. (2023). Pathologic Response to Neoadjuvant Sequential Chemoradiation Therapy in Locally Advanced Breast Cancer: Preliminary, Translational Results from the French Neo-APBI-01 Trial. Cancers. 15(7). 2030–2030. 3 indexed citations
9.
10.
Cleuziou, Julie, P. Chartier, Martin Carré, et al.. (2021). Total body irradiation using helical tomotherapy: Set-up experience and in-vivo dosimetric evaluation. Cancer/Radiothérapie. 25(3). 213–221. 9 indexed citations
11.
12.
Seigneurin, Arnaud, Camille Verry, M. Bolla, et al.. (2020). External evaluation of the Briganti nomogram to predict lymph node metastases in intermediate-risk prostate cancer patients. World Journal of Urology. 39(5). 1489–1497. 5 indexed citations
13.
Scher, Nathaniel, Sylvie Bonvalot, Christophe Le Tourneau, et al.. (2020). Review of clinical applications of radiation-enhancing nanoparticles. Biotechnology Reports. 28. e00548–e00548. 23 indexed citations
14.
Bort, Guillaume, François Lux, Sandrine Dufort, et al.. (2020). EPR-mediated tumor targeting using ultrasmall-hybrid nanoparticles: From animal to human with theranostic AGuIX nanoparticles. Theranostics. 10(3). 1319–1331. 109 indexed citations
15.
Verry, Camille, Lucie Sancey, Sandrine Dufort, et al.. (2019). Treatment of multiple brain metastases using gadolinium nanoparticles and radiotherapy: NANO-RAD, a phase I study protocol. BMJ Open. 9(2). e023591–e023591. 110 indexed citations
16.
Dufort, Sandrine, Geoffrey Appelboom, Camille Verry, et al.. (2019). Ultrasmall theranostic gadolinium-based nanoparticles improve high-grade rat glioma survival. Journal of Clinical Neuroscience. 67. 215–219. 25 indexed citations
17.
Némoz, Christian, M. Renier, P. Berkvens, et al.. (2018). Significant dose reduction using synchrotron radiation computed tomography: first clinical case and application to high resolution CT exams. Scientific Reports. 8(1). 12491–12491. 16 indexed citations
18.
Kotb, Shady, Alexandre Detappe, François Lux, et al.. (2016). Gadolinium-Based Nanoparticles and Radiation Therapy for Multiple Brain Melanoma Metastases: Proof of Concept before Phase I Trial. Theranostics. 6(3). 418–427. 131 indexed citations
19.
Bolla, M., Camille Verry, Jean-Yves Giraud, et al.. (2014). Results of a cohort of 200 hormone-naïve consecutive patients with prostate cancer treated with iodine 125 permanent interstitial brachytherapy by the same multidisciplinary team. Cancer/Radiothérapie. 18(7). 643–648. 6 indexed citations
20.
Bolla, M., et al.. (2010). Radiothérapie et hormonothérapie pour le cancer de la prostate : acquis et interrogations. Cancer/Radiothérapie. 14(6-7). 510–514. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pierre Mowat Breakdown of academic impact, for papers by Monique van Prooijen Breakdown of academic impact, for papers by David Kryza Breakdown of academic impact, for papers by Hovanes Kalaigian Breakdown of academic impact, for papers by Nathan A. Koonce Breakdown of academic impact, for papers by Ray R. Zhang Breakdown of academic impact, for papers by Rasmus I. Jølck Breakdown of academic impact, for papers by Brian Madajewski Breakdown of academic impact, for papers by Andrew N. Fontanella Breakdown of academic impact, for papers by Joseph J. Grudzinski
Rankless by CCL
2026